Search research articles
Contact Us
Filters
Showing results (111-120 of 135) with videos related to
Page
of 14
Sort By:
Neuroendocrinology
|
April 23, 2004
Expression and function of somatostatin receptor subtype 1 in human growth hormone secreting pituitary tumors deriving from patients partially responsive or resistant to long-term treatment with somatostatin analogs
C Matrone, R Pivonello, A Colao, et al.
Journal of Endocrinological Investigation
|
November 20, 2019
Association between biochemical control and comorbidities in patients with acromegaly: an Italian longitudinal retrospective chart review study
A Colao, L F S Grasso, M Di Cera, et al.
Hormone Research in Paediatrics
|
January 10, 2014
Impaired bone metabolism in glycogen storage disease type 1 is associated with poor metabolic control in type 1a and with granulocyte colony-stimulating factor therapy in type 1b
D Melis, R Pivonello, M Cozzolino, et al.
Journal of Endocrinological Investigation
|
May 2, 2024
Improvement in clinical features of hypercortisolism during osilodrostat treatment: findings from the Phase III LINC 3 trial in Cushing's disease
R Pivonello, M Fleseriu, J Newell-Price, et al.
Journal of Endocrinological Investigation
|
December 30, 2017
Correction to: Pegvisomant in acromegaly: an update
A Giustina, G Arnaldi, F Bogazzi, et al.
Journal of Endocrinological Investigation
|
February 9, 2017
Pegvisomant in acromegaly: an update
A Giustina, G Arnaldi, F Bogazzi, et al.
European Journal of Neurology
|
April 5, 2013
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease
M T Pellecchia, G Santangelo, M Picillo, et al.
Journal of Endocrinological Investigation
|
April 1, 2022
Are there country-specific differences in the use of pegvisomant for acromegaly in clinical practice? An analysis from ACROSTUDY
S Grottoli, A Bianchi, F Bogazzi, et al.
Andrology
|
June 13, 2019
Risk behaviours and alcohol in adolescence are negatively associated with testicular volume: results from the Amico-Andrologo survey
D Gianfrilli, A Ferlin, A M Isidori, et al.
Endocrine
|
June 21, 2020
Discordant biological parameters of remission in acromegaly do not increase the risk of hypertension or diabetes: a study with the Liege Acromegaly Survey database
V Amodru, P Petrossians, A Colao, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 135) with videos related to
Sort By:
Page
of 14
Neuroendocrinology
|
April 23, 2004
Expression and function of somatostatin receptor subtype 1 in human growth hormone secreting pituitary tumors deriving from patients partially responsive or resistant to long-term treatment with somatostatin analogs
C Matrone, R Pivonello, A Colao, et al.
Journal of Endocrinological Investigation
|
November 20, 2019
Association between biochemical control and comorbidities in patients with acromegaly: an Italian longitudinal retrospective chart review study
A Colao, L F S Grasso, M Di Cera, et al.
Hormone Research in Paediatrics
|
January 10, 2014
Impaired bone metabolism in glycogen storage disease type 1 is associated with poor metabolic control in type 1a and with granulocyte colony-stimulating factor therapy in type 1b
D Melis, R Pivonello, M Cozzolino, et al.
Journal of Endocrinological Investigation
|
May 2, 2024
Improvement in clinical features of hypercortisolism during osilodrostat treatment: findings from the Phase III LINC 3 trial in Cushing's disease
R Pivonello, M Fleseriu, J Newell-Price, et al.
Journal of Endocrinological Investigation
|
December 30, 2017
Correction to: Pegvisomant in acromegaly: an update
A Giustina, G Arnaldi, F Bogazzi, et al.
Journal of Endocrinological Investigation
|
February 9, 2017
Pegvisomant in acromegaly: an update
A Giustina, G Arnaldi, F Bogazzi, et al.
European Journal of Neurology
|
April 5, 2013
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease
M T Pellecchia, G Santangelo, M Picillo, et al.
Journal of Endocrinological Investigation
|
April 1, 2022
Are there country-specific differences in the use of pegvisomant for acromegaly in clinical practice? An analysis from ACROSTUDY
S Grottoli, A Bianchi, F Bogazzi, et al.
Andrology
|
June 13, 2019
Risk behaviours and alcohol in adolescence are negatively associated with testicular volume: results from the Amico-Andrologo survey
D Gianfrilli, A Ferlin, A M Isidori, et al.
Endocrine
|
June 21, 2020
Discordant biological parameters of remission in acromegaly do not increase the risk of hypertension or diabetes: a study with the Liege Acromegaly Survey database
V Amodru, P Petrossians, A Colao, et al.
Page
of 14